213 related articles for article (PubMed ID: 15927260)
1. Quinoline antimalarials decrease the rate of beta-hematin formation.
Egan TJ; Ncokazi KK
J Inorg Biochem; 2005 Jul; 99(7):1532-9. PubMed ID: 15927260
[TBL] [Abstract][Full Text] [Related]
2. A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds.
Ncokazi KK; Egan TJ
Anal Biochem; 2005 Mar; 338(2):306-19. PubMed ID: 15745752
[TBL] [Abstract][Full Text] [Related]
3. [Comparative observation on inhibition of hemozoin formation and their in vitro and in vivo anti-schistosome activity displayed by 7 antimalarial drugs].
Xue J; Jiang B; Liu CS; Sun J; Xiao SH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Jun; 31(3):161-9. PubMed ID: 24812850
[TBL] [Abstract][Full Text] [Related]
4. Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs.
Parapini S; Basilico N; Pasini E; Egan TJ; Olliaro P; Taramelli D; Monti D
Exp Parasitol; 2000 Dec; 96(4):249-56. PubMed ID: 11162378
[TBL] [Abstract][Full Text] [Related]
5. Crystal nucleation, growth, and morphology of the synthetic malaria pigment beta-hematin and the effect thereon by quinoline additives: the malaria pigment as a target of various antimalarial drugs.
Solomonov I; Osipova M; Feldman Y; Baehtz C; Kjaer K; Robinson IK; Webster GT; McNaughton D; Wood BR; Weissbuch I; Leiserowitz L
J Am Chem Soc; 2007 Mar; 129(9):2615-27. PubMed ID: 17290993
[TBL] [Abstract][Full Text] [Related]
6. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity.
Biot C; Taramelli D; Forfar-Bares I; Maciejewski LA; Boyce M; Nowogrocki G; Brocard JS; Basilico N; Olliaro P; Egan TJ
Mol Pharm; 2005; 2(3):185-93. PubMed ID: 15934779
[TBL] [Abstract][Full Text] [Related]
7. Alcohols induce beta-hematin formation via the dissociation of aggregated heme and reduction in interfacial tension of the solution.
Huy NT; Maeda A; Uyen DT; Trang DT; Sasai M; Shiono T; Oida T; Harada S; Kamei K
Acta Trop; 2007 Feb; 101(2):130-8. PubMed ID: 17274939
[TBL] [Abstract][Full Text] [Related]
8. Antimalarials inhibit hematin crystallization by unique drug-surface site interactions.
Olafson KN; Nguyen TQ; Rimer JD; Vekilov PG
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7531-7536. PubMed ID: 28559329
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Quinoline and Non-Quinoline Inhibitors on the Kinetics of Lipid-Mediated β-Hematin Crystallization.
Fitzroy SM; Gildenhuys J; Olivier T; Tshililo NO; Kuter D; de Villiers KA
Langmuir; 2017 Aug; 33(30):7529-7537. PubMed ID: 28689414
[TBL] [Abstract][Full Text] [Related]
10. Interactions of quinoline antimalarials with hematin in solution.
Egan TJ
J Inorg Biochem; 2006 May; 100(5-6):916-26. PubMed ID: 16384600
[TBL] [Abstract][Full Text] [Related]
11. In situ localization and structural analysis of the malaria pigment hemozoin.
Frosch T; Koncarevic S; Zedler L; Schmitt M; Schenzel K; Becker K; Popp J
J Phys Chem B; 2007 Sep; 111(37):11047-56. PubMed ID: 17718555
[TBL] [Abstract][Full Text] [Related]
12. B-hematin.
Blauer G; Akkawi M
Biochem Mol Biol Int; 1995 Feb; 35(2):231-5. PubMed ID: 7663376
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action.
Onyeibor O; Croft SL; Dodson HI; Feiz-Haddad M; Kendrick H; Millington NJ; Parapini S; Phillips RM; Seville S; Shnyder SD; Taramelli D; Wright CW
J Med Chem; 2005 Apr; 48(7):2701-9. PubMed ID: 15801861
[TBL] [Abstract][Full Text] [Related]
14. The single crystal X-ray structure of β-hematin DMSO solvate grown in the presence of chloroquine, a β-hematin growth-rate inhibitor.
Gildenhuys J; le Roex T; Egan TJ; de Villiers KA
J Am Chem Soc; 2013 Jan; 135(3):1037-47. PubMed ID: 23253048
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
[TBL] [Abstract][Full Text] [Related]
16. Probing the role of the covalent linkage of ferrocene into a chloroquine template.
Biot C; Daher W; Ndiaye CM; Melnyk P; Pradines B; Chavain N; Pellet A; Fraisse L; Pelinski L; Jarry C; Brocard J; Khalife J; Forfar-Bares I; Dive D
J Med Chem; 2006 Jul; 49(15):4707-14. PubMed ID: 16854077
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial Quinoline Drugs Inhibit β-Hematin and Increase Free Hemin Catalyzing Peroxidative Reactions and Inhibition of Cysteine Proteases.
Herraiz T; Guillén H; González-Peña D; Arán VJ
Sci Rep; 2019 Oct; 9(1):15398. PubMed ID: 31659177
[TBL] [Abstract][Full Text] [Related]
18. Deconstructing Quinoline-Class Antimalarials to Identify Fundamental Physicochemical Properties of Beta-Hematin Crystal Growth Inhibitors.
Olafson KN; Nguyen TQ; Vekilov PG; Rimer JD
Chemistry; 2017 Oct; 23(55):13638-13647. PubMed ID: 28833627
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of beta-hematin formation in acetate solution. Parallels between hemozoin formation and biomineralization processes.
Egan TJ; Mavuso WW; Ncokazi KK
Biochemistry; 2001 Jan; 40(1):204-13. PubMed ID: 11141072
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of beta-haematin formation from suspensions of haematin in aqueous benzoic acid.
Egan TJ; Tshivhase MG
Dalton Trans; 2006 Nov; (42):5024-32. PubMed ID: 17060988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
